Fresenius Still Awaits FTC Approval to Buy NxStage Medical - Home Dialysis Central

Fresenius Still Awaits FTC Approval to Buy NxStage Medical

The company expects the delayed transaction to close early this year.

Read the full article » | Posted 01-11-2019

Related Articles

Cannulation and PD Catheter Training Aids Posted 04-19-2023
Peritoneal Dialysis: Expanding Patient Options and Reducing Complications Posted 04-19-2023
FDA Warning Letter for Toxic PD and Home HD Tubing Posted 04-19-2023
Dialyze Direct to Improve Care Coordination for Home Dialysis Patients in Nursing Homes Posted 02-10-2023